Skip to main content
Resource Library
phase 2
Optimizing Adaptive Design for Phase 2 Dose-finding Trials Incorporating Long-term Success and Financial Considerations: A Case Study for Neuropathic Pain
Methodological Extensions of Phase 2 Trial Designs Based on Program-level Considerations: Further Development of a Case Study in Neuropathic Pain
A Randomized, Phase 2 Study Investigating TRV130, a Biased Ligand of the μ-opioid Receptor, for the Intravenous Treatment of Acute Pain
